Patents by Inventor Tellis Alexander Martin

Tellis Alexander Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mucolytic mercaptoacylamidobenzamides and process of using same
    Patent number: 4096277
    Abstract: A mucolytic process is disclosed which comprises contacting N-(2-hydroxyethyl)mercaptoacetamidobenzamides or mercaptoacylamidobenzoic acids, mercaptoacetylsulfanilic acids and alkanoylthio derivatives thereof with mucus. Illustrative of compounds useful in the mucolytic process of the present invention are 4-(2-mercaptoacetamido)-benzoic acid and N-(2-mercaptoacetyl)sulfanilic acid.
    Type: Grant
    Filed: October 18, 1976
    Date of Patent: June 20, 1978
    Assignee: Mead Johnson & Company
    Inventors: Tellis Alexander Martin, William Timmey Comer
  • Mercaptoacylamidobenzoyl glycine and mucolytic process
    Patent number: 4093739
    Abstract: N-[3-(mercaptoacetylamino)benzoyl]glycine, alkali metal and amine salts thereof are potent topically effective mucolytic agents.
    Type: Grant
    Filed: June 15, 1977
    Date of Patent: June 6, 1978
    Assignee: Mead Johnson & Company
    Inventor: Tellis Alexander Martin
  • Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process
    Patent number: 4005222
    Abstract: A mucolytic process is disclosed which comprises contacting N-(2-hydroxyethyl)mercaptoacetamidobenzamides or mercaptoacylamidobenzoic acids, mercaptoacetylsulfanilic acids and alkanoylthio derivatives thereof with mucus. Illustrative of compounds useful in the mucolytic process of the present invention are 4-(2-mercaptoacetamido)benzoic acid and N-(2-mercaptoacetyl)sulfanilic acid.
    Type: Grant
    Filed: May 21, 1975
    Date of Patent: January 25, 1977
    Assignee: Mead Johnson & Company
    Inventors: Tellis Alexander Martin, William Timmey Comer
  • Crystalline ammonium N-acetyl-L-cysteinate and mucolytic process
    Patent number: 3965167
    Abstract: The ammonium salt of N-acetyl-L-cysteine is a relatively non-hygroscopic crystalline solid which renders it particularly useful for administration by insufflation in the treatment of bronchopulmonary disease. It is of use in a mucolytic process wherein bronchopulmonary mucus is contacted with solid ammonium N-acetyl-L-cysteinate utilizing only the energy of the inspiratory action of the inhaler.
    Type: Grant
    Filed: February 3, 1972
    Date of Patent: June 22, 1976
    Assignee: Mead Johnson & Company
    Inventors: Eugene Emanuel Hamlow, Tellis Alexander Martin